Molecular basis of cholesterol homeostasis: Lessons from Tangier disease and ABCA1

Trends in Molecular Medicine

Volumn 8, Issue 4, 2002, Pages 168-173

  Oram, John F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ABC TRANSPORTER; ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MEMBRANE PROTEIN; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RETINOID X RECEPTOR; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ABCA1 GENE; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DISEASE SEVERITY; DRUG ELIMINATION; GENE ISOLATION; HUMAN; LIVER CLEARANCE; MOLECULAR DYNAMICS; PROTEIN SECRETION; REVIEW; TANGIER DISEASE;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; HOMEOSTASIS; HUMANS; LIPOPROTEINS, HDL; LIVER; MACROPHAGES; MODELS, BIOLOGICAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TANGIER DISEASE;

EID: 0036214524     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02289-X     Document Type: Review

References (72)

1. The caveolae membrane system
2. Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptcl
3. Development of the lipid-rich core in human atherosclerosis
4. A receptor-mediated pathway for cholesterol homeostasis
5. Molecular physiology of reverse cholesterol transport
6. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
7. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
8. Familial high density lipoprotein deficiency: Tangier disease
9. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease
10. Defective removal of cellular cholesterol and phospholipids by apolipoproteinA-I in Tangier disease
11. Mutations in ABC 1 in Tangier disease and familial high-density lipoprotein deficiency
12. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
13. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
14. The Tangier disease gene productABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
15. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter
16. ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space
17. Cloning of two novel ABC transporters mapping on human chromosome 9
18. The human ATP-binding cassette (ABC) transporter superfamily
19. ATP-bindingcassette transporter A1 mediates cellular secretion of alpha-tocopherol
20. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages
21. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
22. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter
23. Preferential ATP-binding cassette transporter Al-mediated cholesterol efflux from late endosomes/lysosomes
24. Synthetic amphipathic helical peptides that mimic apolipoproteinA-I in clearing cellular cholesterol
25. ABCA1: The gatekeeper for eliminating excess tissue cholesterol
26. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway
27. Cellular localization and trafficking of the human ABCA1 transporter
28. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1
29. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
30. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
31. Regulation and activity of the human abca 1 gene in transgenic mice
32. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels
33. Is it time to modify the reverse cholesterol transport model?
34. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man
35. Charting the fate of the 'good cholesterol': Identification and characterization of the high-density lipoprotein receptor SR-BI
36. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion
37. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile
38. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
39. Cell cholesterol efflux: Integration of old and new observations provides new insights
40. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice
41. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
42. Massive cholesterol ester accumulation in hepatocytes and intestinal epithelial cells caused by ABC1 mutation in WHAM chickens
43. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
44. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism
45. Hepatobiliary cholesterol transport is not impaired in Abcal -null mice lacking HDL
46. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice
47. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
48. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
49. Common genetic variation in abca 1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease
50. The ATP binding cassette transporter A1 (ABCA1) modulates the development ofaortic atherosclerosis in C57BL/6 and apoE-knockout mice
51. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR
52. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha
53. Nuclear receptor regulation of cholesterol and bile acid metabolism
54. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta
55. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells
56. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
57. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
58. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacentABC transporters
59. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
60. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors
61. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
62. Role of LXRs in control of lipogenesis
63. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
64. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma
65. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
66. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
67. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
68. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
69. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
70. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A- I by cAMP
71. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
72. Identification of cAMP analogue inducible genes in RAW264 macrophages